Select a community
Mood Conditions including Depression, Anxiety, Bipolar, OCD, and PTSD
Find out more about the PatientsLikeMe
Mood Conditions Community
Home > Community Treatment Reports > Promethazine Treatment Report
What is Promethazine?

Promethazine is an antiemetic and antihistamine. It is used to relieve the symptoms of allergic reactions, nausea, motion sickness. It is also use as a sedative, as adjunctive therapy for postoperative pain, anesthetic and anaphylactic reactions.

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
5 45%
Mild
3 27%
None
3 27%

Most commonly reported side effects

Drowsiness
7 88%
Excessive sedation
2 25%
Sedation
1 13%
Grogginess
1 13%
Groggy in morning
1 13%
Allergies
1 13%
  • Mild
  • Moderate
  • Severe

Dosages

  12.5mg as needed 2 25mg as needed 25mg as needed 25mg/mL as needed 25 mg daily 50 mg daily
  2 Number of Patients: 2 1 Number of Patients: 1 14 Number of Patients: 14 3 Number of Patients: 3 1 Number of Patients: 1 4 Number of Patients: 4  

Stop Reasons

Why Patients Stopped Taking Promethazine (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe
3 50% Side effects too severe: 50%
Other
3 50% Other: 50%
Doctor's advice
2 33% Doctor's advice: 33%

See all 6 patients who’ve stopped taking Promethazine

Duration See details about how long patients take this treatment ▼

Currently Taking Promethazine

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0

Stopped Taking Promethazine

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
8 73%
Usually
3 27%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
2 18%
Not at all
9 82%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
7 64%

See more information, including instructions, precautions, side effects, and interactions.

Report created on March 20, 2010.